Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia

[1]  T. Lister,et al.  High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma , 2004, Cancer Chemotherapy and Pharmacology.

[2]  Y. C. Chen,et al.  Treatment of refractory acute leukemia with high-dose cytosine arabinoside. , 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[3]  W. Woods,et al.  Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Fey.  High-dose cytosine arabinoside therapy for refractory leukemia. , 1984, Blood.

[5]  C. Spurr,et al.  Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. , 1984, Blood.

[6]  H. Lazarus.  Acute cerebellar dysfunction with high-dose Ara-C therapy. , 1984, Cancer.

[7]  F. Mandelli,et al.  Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma. , 1984, Leukemia research.

[8]  R. Willemze,et al.  TREATMENT OF REFRACTORY ACUTE LEUKAEMIA WITH HIGH DOSE CYTOSINE ARABINOSIDE , 1982, British journal of haematology.

[9]  B. Morgenstern,et al.  Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia. , 1982, Cancer research.

[10]  Y. Cheng,et al.  Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia. , 1982, Medical and pediatric oncology.

[11]  U. Roessmann,et al.  Central nervous system toxicity of high‐dose systemic cytosine arabinoside , 1981, Cancer.

[12]  J. Bertino,et al.  High dose cytosine arabinoside (HDARAC) in refractory acute leukemia , 1979, Cancer.

[13]  B. Drewinko,et al.  The effects of arabinosylcytosine on cultured human lymphoma cells. , 1972, Cancer research.

[14]  M. Chu,et al.  COMPARATIVE STUDIES OF LEUKEMIC CELLS SENSITIVE AND RESISTANT TO CYTOSINE ARABINOSIDE. , 1965, Biochemical pharmacology.